- Previous Close
22.60 - Open
22.60 - Bid 22.60 x --
- Ask 23.60 x --
- Day's Range
22.60 - 22.60 - 52 Week Range
22.60 - 45.20 - Volume
80 - Avg. Volume
5 - Market Cap (intraday)
436.191M - Beta (5Y Monthly) 1.00
- PE Ratio (TTM)
11.41 - EPS (TTM)
1.98 - Earnings Date Apr 28, 2025 - May 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
www.usana.com1,700
Full Time Employees
December 28
Fiscal Year Ends
Sector
Industry
Recent News: USJ.F
View MorePerformance Overview: USJ.F
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: USJ.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: USJ.F
View MoreValuation Measures
Market Cap
436.19M
Enterprise Value
297.86M
Trailing P/E
11.40
Forward P/E
9.07
PEG Ratio (5yr expected)
0.76
Price/Sales (ttm)
0.56
Price/Book (mrq)
0.89
Enterprise Value/Revenue
0.38
Enterprise Value/EBITDA
3.33
Financial Highlights
Profitability and Income Statement
Profit Margin
4.92%
Return on Assets (ttm)
6.00%
Return on Equity (ttm)
7.76%
Revenue (ttm)
854.5M
Net Income Avi to Common (ttm)
42.03M
Diluted EPS (ttm)
1.98
Balance Sheet and Cash Flow
Total Cash (mrq)
181.77M
Total Debt/Equity (mrq)
6.69%
Levered Free Cash Flow (ttm)
57.95M